Mattias Klintemar
Chairman
medicine
Dilafor AB
Sweden
Biography
Investment Director, Östersjöstiftelsen, Mr. Klintemar represents one of the major shareholders in Dilafor. Mr. Klintemar has a long financial background from various management positions, including auditor and consultant at Arthur Andersen, financial controller at HSBC, CFO and corporate finance executive at ABG Sundal Collier and CEO of Morphic Technologies (which he transferred to the property company Amasten). He is currently a board member of Ceba, Phoniro and chairman of Lyyn. Mr. Klintemar holds a Bsc (Sw Civilekonom) in Accounting and Finance.
Research Interest
MEDICINE
